Krebs Biochemicals & Industries Ltd-$
Krebs Biochemicals & Industries Ltd-$ (KREBSBIO) last traded at ₹53.2, a market capitalisation of ₹115 crore. Over the past 52 weeks the stock has ranged between ₹38.3 and ₹82.5. Krebs Biochemicals & Industries Ltd-$ last reported results for the quarter ended Jun 2026, with sales of ₹6.98 crore and net profit of ₹-2.48 crore. Figures are as of 25 Aug 2026 and are not real time.
Krebs Biochemicals & Industries Ltd-$ share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Krebs Biochemicals & Industries Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹6.98 cr, up 27.4% from ₹5.48 cr a year earlier. Net profit was ₹-2.48 cr, up 53.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 12.86 | 11.47 | 6.1 | 5.48 | 4.17 | 7.27 | 6.81 | 6.98 |
| Expenses | 15.58 | 16.18 | 11.51 | 7.57 | 6.97 | 6.97 | 7.67 | 6.16 |
| Operating profit | -2.72 | -4.71 | -5.41 | -2.09 | -2.8 | 0.3 | -0.86 | 0.82 |
| OPM % | -21.15% | -41.06% | -88.69% | -38.14% | -67.15% | 4.13% | -12.63% | 11.75% |
| Other income | 0.09 | 0.25 | 0.34 | 0.01 | 0.01 | 0 | 2 | 0.16 |
| Interest | 1.42 | 1.56 | 1.61 | 1.65 | 1.73 | 1.79 | 1.91 | 1.88 |
| Depreciation | 1.71 | 1.72 | 1.57 | 1.6 | 1.62 | 1.63 | 1.57 | 1.59 |
| Profit before tax | -5.76 | -7.74 | -8.25 | -5.33 | -6.14 | -3.12 | -2.34 | -2.49 |
| Tax % | 0.00% | 0.00% | 0.24% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net profit | -5.76 | -7.74 | -8.27 | -5.32 | -6.14 | -3.13 | -2.34 | -2.48 |
| EPS (₹) | -2.67 | -3.59 | -3.84 | -2.47 | -2.85 | -1.45 | -1.09 | -1.15 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Krebs Biochemicals & Industries Ltd-$ annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 54 | 60 | 52 | 50 | 43 | 24 | 25 |
| Operating profit | -18 | -34 | -16 | -9 | -15 | -5 | -3 |
| OPM % | -33% | -57% | -30% | -17% | -35% | -23% | -10% |
| Net profit | -28 | -45 | -25 | -20 | -27 | -17 | -14 |
| EPS (₹) | -14.45 | -20.65 | -11.45 | -9.15 | -12.50 | -7.85 | -6.54 |
TTM is the trailing twelve months to the most recent quarter.
Krebs Biochemicals & Industries Ltd-$ growth and returns
- 10 Years
- 35%
- 5 Years
- -15%
- 3 Years
- -23%
- TTM
- -30%
- 10 Years
- 0%
- 5 Years
- 7%
- 3 Years
- 10%
- TTM
- 48%
- 10 Years
- -3%
- 5 Years
- -18%
- 3 Years
- -10%
- 1 Year
- -29%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- %
Krebs Biochemicals & Industries Ltd-$ shareholding pattern
Promoters held 72.74% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.50%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% |
| FIIs | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% |
| Public | 26.76% | 26.76% | 26.75% | 26.76% | 26.76% | 26.76% | 26.77% | 26.76% |
| No. of shareholders | 9,425 | 9,091 | 8,798 | 9,118 | 8,912 | 8,710 | 8,553 | 8,521 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Krebs Biochemicals & Industries Ltd-$ corporate filings
- The Company has enclosed herewith copy of newpapers advertiesment of unaudited financial results for the quarter ended 30.06.2026Company Updatemedium impact
Cruxal's analysis: Krebs Biochemicals & Industries Limited reported a net loss of 2.48 crore for the quarter…
Read the full analysis - Outcome of BMBoard Meetinglow impact
Cruxal's analysis: Krebs Biochemicals and Industries Limited reported a net loss of 2.48 crore for the…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Krebs Biochemicals & Industries Ltd-$
Cruxal reads every Krebs Biochemicals & Industries Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.